Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,710
  • Shares Outstanding, K 29,929
  • Annual Sales, $ 16,020 K
  • Annual Income, $ -23,850 K
  • 60-Month Beta 2.63
  • Price/Sales 0.36
  • Price/Cash Flow N/A
  • Price/Book 2.71
Trade VVOS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.81
  • Most Recent Earnings -0.15 on 08/16/23
  • Next Earnings Date 08/14/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 75.46%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,343.48% on 03/20/23
  • IV Low 0.00% on 09/27/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 759
  • Open Int (30-Day) 760

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1808 +5.14%
on 09/22/23
0.2748 -30.82%
on 09/05/23
-0.0759 (-28.53%)
since 08/25/23
3-Month
0.1808 +5.14%
on 09/22/23
0.5606 -66.09%
on 08/08/23
-0.3124 (-62.17%)
since 06/27/23
52-Week
0.1808 +5.14%
on 09/22/23
2.9620 -93.58%
on 01/04/23
-0.5959 (-75.81%)
since 09/27/22

Most Recent Stories

More News
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 12.99% and 94.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

MRNS : 8.00 (+2.11%)
VVOS : 0.1901 (-0.37%)
Exscientia PLC Sponsored ADR (EXAI) Reports Q3 Loss, Lags Revenue Estimates

Exscientia PLC Sponsored ADR (EXAI) delivered earnings and revenue surprises of -72.73% and 47.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

EXAI : 4.71 (+0.64%)
VVOS : 0.1901 (-0.37%)
Impel Pharmaceuticals Inc. (IMPL) Reports Q3 Loss, Lags Revenue Estimates

Impel Pharmaceuticals Inc. (IMPL) delivered earnings and revenue surprises of -50.57% and 40.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

IMPL : 0.5800 (+7.45%)
VVOS : 0.1901 (-0.37%)
Chinook Therapeutics (KDNY) Reports Q3 Loss, Tops Revenue Estimates

Chinook (KDNY) delivered earnings and revenue surprises of -33.87% and 614.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

KDNY : 40.39 (+0.22%)
VVOS : 0.1901 (-0.37%)
Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 2.56% and 1.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HRTX : 0.9909 (-0.91%)
VVOS : 0.1901 (-0.37%)
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 5.75% and 4.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 28.90 (-0.14%)
VVOS : 0.1901 (-0.37%)
Gain Therapeutics, Inc. (GANX) Reports Q2 Loss, Tops Revenue Estimates

Gain Therapeutics, Inc. (GANX) delivered earnings and revenue surprises of -22.86% and 46.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

GANX : 3.21 (+0.31%)
VVOS : 0.1901 (-0.37%)
Corcept Therapeutics (CORT) Q2 Earnings Lag Estimates

Corcept (CORT) delivered earnings and revenue surprises of -4% and 1.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CORT : 32.37 (-0.31%)
VVOS : 0.1901 (-0.37%)
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances

Vivos Therapeutics, Inc . (NASDAQ: VVOS) is pleased to announce that it has received multiple Class I clearances by the Therapeutic Goods Administration for multiple indications to include the treatment...

VVOS : 0.1901 (-0.37%)
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea

Study Recently Presented at the SLEEP 2022 Annual Meeting...

VVOS : 0.1901 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

See More

Key Turning Points

3rd Resistance Point 0.2234
2nd Resistance Point 0.2139
1st Resistance Point 0.2020
Last Price 0.1901
1st Support Level 0.1806
2nd Support Level 0.1711
3rd Support Level 0.1592

See More

52-Week High 2.9620
Fibonacci 61.8% 1.8996
Fibonacci 50% 1.5714
Fibonacci 38.2% 1.2432
Last Price 0.1901
52-Week Low 0.1808

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar